Sunday, 19 August 2018
Latest news
Main » Some breast cancer treatments may impact heart function

Some breast cancer treatments may impact heart function

02 February 2018

In its first scientific statement on cardiovascular disease and breast cancer, the American Heart Association reported about heart tissue damage, coronary events and reduced heart function that may be associated with state-of-the-art breast cancer treatment.

Prostate Cancer UK said the number of men dying from prostate cancer every year has overtaken the number of women dying from breast cancer, with 11,819 men now dying from prostate cancer in the UK every year - the equivalent of one man every 45 minutes.

But Prostate Cancer UK says the latest statistics should act as a wake-up call for anyone who still may have imagined that this disease is somehow minor, in demographic terms, compared to the ones we hear about all the time. This should not scare the patient from taking treatment for breast cancer but should be in a consistent communication with their doctor about the kind of treatment being given to them. Plans to create an accurate test fit for use as part of a nationwide prostate cancer screening programme, as well as developing new treatments for advanced prostate cancer are already well underway.

Chemotherapeutic agents (eg, anthracyclines, alkylating agents, taxanes, and antimetabolite drugs), endocrine therapies, HER2-targeted therapies (eg, trastuzumab, pertuzumab), novel emerging therapies, and radiotherapy are associated with increased incidence of many cardiovascular diseases including left ventricular dysfunction (LVD), arrhythmias, conduction abnormalities, heart failure, thrombosis, and cardiomyopathy. While much of the information is known to oncologists, the report could be a helpful reference tool for patients as well as primary care, emergency room and other doctors who treat breast cancer patients.

More news: After Turkish player, Super Bowl LII seat bought using cryptocurrency

Researchers enrolled 537 patients with newly diagnosed early-stage, breast cancer from multiple practices spread throughout four states.

The diseases share many common risk factors such as obesity, smoking and too little exercise, so reducing these can help. Administering doxorubicin more slowly can be both beneficial and protective, studies have shown, and result in lower rates of heart failure.

However, they can also cause heart failure and various other severe heart problems, even years after the treatment.

The anthracycline class of chemotherapeutic drugs can trigger abnormal heart rhythms, which may be benign or potentially life-threatening. And, some treatments - like antimetabolites - can cause spasm of the heart arteries, which can cause chest pain symptoms but could lead to heart attacks as well.

More news: Trudeau to hold town hall in BC following Trans Mountain pipeline endorsement

The publication explores the shared risk factors for breast cancer and cardiovascular disease and the cardiotoxic effects of breast cancer treatments.

About 12 percent of American women will develop breast cancer during their lifetime.

Despite the alarming figures, the charity added the shift does not represent a worsening situation for prostate cancer and men diagnosed today are two-and-a-half times more likely to live for 10 years or more than if they were diagnosed in 1990. She said that cardiologists should also be involved to help protect women's hearts before, during, and after breast cancer treatments.

The biggest cancer killers in the United Kingdom remain lung and bowel cancer, with prostate now in third place. "And that's why Life's Simple 7 is important for all patients with and without breast cancer".

More news: John Wall out for All-Star game. Will Dragic be his replacement?

There are certain medications individuals can take to preventively combat their risk of both CVD and breast cancer, the authors wrote.

Some breast cancer treatments may impact heart function